SAI - Detailed view

MOMETASON POLLEN Sandoz Nasenspray 50 mcg 60 Dos

Drug

Name

Mometason Pollen Sandoz, Nasenspray

Field of application

Symptomatische Behandlung der saisonalen allergischen Rhinitis bei Erwachsenen nach ärztlicher Erstdiagnose

ATC

R01AD09 - MOMETASONE

12.02.3. – nasal drugs with corticosteroids

Use

HAM – Human medicine

pharmaceutical form

NASSS – nasal spray, suspension

Remedy code

S – synthetic products for human use

Dispensing categories

B – Dispensed on prescription by a physician or veterinarian (B)

Authorisation status

Z – approved

Authorisation number

66274

Initial registration date

8/11/2017

Expiry date

12/31/9999

Dosage strength

Name

Mometason Pollen Sandoz, Nasenspray

Field of application

Symptomatische Behandlung der saisonalen allergischen Rhinitis bei Erwachsenen nach ärztlicher Erstdiagnose

Dosage strength number

Authorisation status

Z – approved

Package

GTIN**

7680662740013

Trade status*

No information made available

Status

A/R – Authorised / referenced

Package size

60 Single-dose(s)

Package code

001

Authorisation status

Z – approved

Declaration

Component

Active substance

0.5 mg mometasoni-17 furoas
0.51731 mg mometasoni-17 furoas monohydricus
50 µg mometasoni-17 furoas

Excipient

cellulosum microcristallinum et carmellosum natricum
glycerolum
acidum citricum monohydricum
natrii citras dihydricus
polysorbatum 80
0.2 mg benzalkonii chloridum
aqua ad iniectabile

Authorisation holder

GLN**

7601001029439

Address

Sandoz Pharmaceuticals AG
6343 Risch (ZG)

Date of revision of the text

6/29/2023

Information for prof.

Leaflet

Report error

Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.